Literature DB >> 28782608

Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.

Li Yang1, P Charles Lin2.   

Abstract

Treatment of cancer metastasis has been largely ineffective. It is paramount to understand the mechanisms underlying the metastatic process, of which the tumor microenvironment is an indispensable participant. What are the critical cellular and molecular players at the primary tumor site where metastatic cascade initiates? How is tumor-associated inflammation regulated? How do altered vasculatures contribute to metastasis? What is the dynamic nature or heterogeneity of primary tumors and what are the challenges to catch a moving target? This review summarizes recent progress, mechanistic understanding, and options for metastasis-targeted therapy. Published by Elsevier Ltd.

Entities:  

Keywords:  Heterogeneity; Inflammation/Immune; Microenvironment; Tumor metastasis; Tumor suppressor

Mesh:

Substances:

Year:  2017        PMID: 28782608      PMCID: PMC5698110          DOI: 10.1016/j.semcancer.2017.08.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  196 in total

Review 1.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

2.  Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.

Authors:  Reginald Hill; Yurong Song; Robert D Cardiff; Terry Van Dyke
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

3.  Commentary on "The evolutionary history of lethal metastatic prostate cancer." Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JM, Papaemmanuil E, Brewer DS, Kallio HM, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC, ICGC Prostate UK Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS, University of Washington-Urology, Seattle, WA. Nature 2015; 520(7547):353-7.

Authors:  Daniel Lin
Journal:  Urol Oncol       Date:  2016-11       Impact factor: 3.498

4.  TGF-β signaling in myeloid cells is required for tumor metastasis.

Authors:  Yanli Pang; Sudheer Kumar Gara; Bhagelu R Achyut; Zhaoyang Li; Hannah H Yan; Chi-Ping Day; Jonathan M Weiss; Giorgio Trinchieri; John C Morris; Li Yang
Journal:  Cancer Discov       Date:  2013-05-09       Impact factor: 39.397

5.  Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.

Authors:  Kou-Gi Shyu; Feng-Lin Hsu; Ming Jen Wang; Bao-Wei Wang; Shankung Lin
Journal:  Exp Cell Res       Date:  2007-02-02       Impact factor: 3.905

6.  De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

Authors:  Karin E de Visser; Lidiya V Korets; Lisa M Coussens
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

7.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

Review 8.  Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

Authors:  Robert G Bristow; Richard P Hill
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  Evolution of neoplastic cell lineages in Barrett oesophagus.

Authors:  M T Barrett; C A Sanchez; L J Prevo; D J Wong; P C Galipeau; T G Paulson; P S Rabinovitch; B J Reid
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

10.  The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.

Authors:  J Turpin; C Ling; E J Crosby; Z C Hartman; A M Simond; L A Chodosh; J P Rennhack; E R Andrechek; J Ozcelik; M Hallett; G B Mills; R D Cardiff; J W Gray; O L Griffith; W J Muller
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

View more
  40 in total

Review 1.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

Review 2.  Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment.

Authors:  Mohd Rihan; Lakshmi Vineela Nalla; Anil Dharavath; Amit Shard; Kiran Kalia; Amit Khairnar
Journal:  Cancer Microenviron       Date:  2019-06-10

3.  TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.

Authors:  Heng-Jia Liu; Patrick H Lizotte; Heng Du; Maria C Speranza; Hilaire C Lam; Spencer Vaughan; Nicola Alesi; Kwok-Kin Wong; Gordon J Freeman; Arlene H Sharpe; Elizabeth P Henske
Journal:  JCI Insight       Date:  2018-04-19

4.  Synergistic effects of arsenic trioxide combined with Salmonella typhimurium in treating the advanced hepatocellular carcinoma in rat models.

Authors:  Qing Zhao; Ying Wang; Wen-Tao Li
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 5.  Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options.

Authors:  Jae Young So; Joyce Ohm; Stan Lipkowitz; Li Yang
Journal:  Pharmacol Ther       Date:  2022-07-21       Impact factor: 13.400

6.  CXCL3 Signaling in the Tumor Microenvironment.

Authors:  Niradiz Reyes; Stephanie Figueroa; Raj Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma.

Authors:  Weicheng Duan; Kang Wang; Yijie Duan; Xiuyi Chen; Xufeng Chu; Ping Hu; Bo Xiong
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 8.  The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.

Authors:  Raghav Chandra; Neeraja Balachandar; Sam Wang; Scott Reznik; Herbert Zeh; Matthew Porembka
Journal:  Cancer Gene Ther       Date:  2020-10-02       Impact factor: 5.987

Review 9.  JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation.

Authors:  Shing Yau Tam; Helen Ka-Wai Law
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

10.  Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma.

Authors:  Qiangqiang Zhao; Duanfeng Jiang; Xiaoying Sun; Qiuyu Mo; Shaobin Chen; Wansong Chen; Rong Gui; Xianjun Ma
Journal:  J Nanobiotechnology       Date:  2021-06-13       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.